Skip to main content
Signal8
Dentzer James E profile photo

James E. Dentzer

CIK: 0001400977

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)13 (92.9%)

Compensation grants

Other (G, F, J, C, D, …)1 (7.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Imunon, Inc. logo
IMNN

Imunon, Inc.

Director
CURIS INC logo
CRIS

CURIS INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jul 31, 2026
    Award(A)
    Direct
    6.9K shares at avg. $1.59$11K
  • CURIS INC logo
    CRIS

    CURIS INC

    Jul 7, 2026
    Award(A)

    Employee stock option (right to buy)

    Direct
    110.1K shares at avg. $5.29-
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    May 22, 2026
    Award(A)
    Direct
    11.1K shares at avg. $2.20$25K
  • CURIS INC logo
    CRIS

    CURIS INC

    Mar 20, 2026
    Conversion(C)
    Direct
    133.3K shares-
  • CURIS INC logo
    CRIS

    CURIS INC

    Mar 17, 2026
    Award(A)

    Series B Warrant (right to buy)

    Direct
    133.3K shares-
  • CURIS INC logo
    CRIS

    CURIS INC

    Mar 17, 2026
    Award(A)

    Series A Warrant (right to buy)

    Direct
    133.3K shares-
  • CURIS INC logo
    CRIS

    CURIS INC

    Mar 17, 2026
    Award(A)

    Series C Warrant (right to buy)

    Direct
    133.3K shares-
  • CURIS INC logo
    CRIS

    CURIS INC

    Mar 17, 2026
    Award(A)

    Series B Convertible Preferred Stock

    Direct
    100 shares-
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jan 2, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    4.4K shares-
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Aug 4, 2025
    Award(A)
    Direct
    3.3K shares at avg. $9.20$31K
  • CURIS INC logo
    CRIS

    CURIS INC

    May 20, 2025
    Award(A)

    Employee stock option (right to buy)

    Direct
    360K shares at avg. $3.13-
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Mar 14, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    3.8K shares-
  • CURIS INC logo
    CRIS

    CURIS INC

    Jan 28, 2025
    Award(A)

    Employee stock option (right to buy)

    Direct
    40K shares at avg. $3.13-
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Sep 6, 2024
    Award(A)

    Stock Option (Right to Buy)

    Direct
    3.6K shares-

1-14 of 14

About Dentzer James E

Dentzer James E (SEC CIK 0001400977) files insider reports with the SEC as Director of Imunon, Inc. (IMNN) and President & CEO of CURIS INC (CRIS).

Signal8 holds 11 ownership filings by Dentzer James E, all Form 4s, filed between Sep 10, 2024 and Aug 4, 2026. Those filings report 14 transactions, from Sep 6, 2024 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Dentzer James E's filings is in LAWRENCEVILLE, NJ.

Recent filings by Dentzer James E

  • Jul 31, 2026: Grant or award of IMNN shares (Form 4, code A).
  • Jul 7, 2026: Grant or award of CRIS derivative securities (Form 4, code A).
  • May 22, 2026: Grant or award of IMNN shares (Form 4, code A).
  • Mar 20, 2026: Conversion of CRIS shares (Form 4, code C).
  • Mar 17, 2026: Grants or awards of CRIS derivative securities (4 lines, Form 4, code A).

Other insiders filing for Imunon, Inc. (IMNN)

How to read Form 4 transaction codes